Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Dysport for post-stroke upper limb spasticity
2015-000554-38Phase 3Completed
- Sponsor
- Ipsen
- Start
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in upper extremity spasticity and stroke comparing Dysport Solution 1000 U with Placebo (2 arms). Primary endpoint: Modified Ashworth Scale raw score in the primary targeted muscle group. Started May 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
upper extremity spasticitystroke
Beyond the preview
Go deeper on 2015-000554-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000554-38.